Publications by authors named "Premini Mahendra"

Claim this Profile
C
CD8(+) T-cell immunity against cancer-testis antigens develops following allogeneic stem cell transplantation and reveals a potential mechanism for the graft-versus-leukemia effect.
Andrew McLarnon, Karen P Piper, Oliver C Goodyear, Julie M Arrazi, Premini Mahendra

Haematologica· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): a comparison of two adapted BFM protocols.
Sudhir Tauro, Lynda Cochrane, Grete Fossum Lauritzsen, Lee Baker, Jan Delabie, Premini Mahendra

Am J Hematol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition.
Sarah Nicholls, Karen P Piper, Fiyaz Mohammed, Timothy R Dafforn, Stefan Tenzer, Premini Mahendra

Proc Natl Acad Sci U S A· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation.
Karen P Piper, Claire Horlock, S John Curnow, Julie Arrazi, Sarah Nicholls, Premini Mahendra

Blood· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.
Karl S Peggs, Anna Sureda, Wendi Qian, Dolores Caballero, Ann Hunter, Premini Mahendra

Br J Haematol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation study.
Jennifer M Bird, Rhian Fuge, Bhawna Sirohi, Jane F Apperley, Ann Hunter, Premini Mahendra

Br J Haematol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation.
Mark Cook, David Briggs, Charles Craddock, Premini Mahendra, Donald Milligan

Blood· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia.
Sudhir Tauro, Charles Craddock, Karl Peggs, Gulnaz Begum, Premini Mahendra

J Clin Oncol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation.
Karl S Peggs, Ann Hunter, Rajesh Chopra, Anne Parker, Premini Mahendra

Lancet· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers.
Mark Cobbold, Naeem Khan, Batoul Pourgheysari, Sudhir Tauro, Dorothy McDonald, Premini Mahendra

J Exp Med· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells.
Fiona J Clark, Richard Gregg, Karen Piper, Debbie Dunnion, Lisa Freeman, Premini Mahendra

Blood· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia.
Mark A Cook, Donald W Milligan, Christopher D Fegan, Philip J Darbyshire, Premini Mahendra

Blood· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease.
Fiona J Clark, Lisa Freeman, Andrzej Dzionek, Jürgen Schmitz, Dominic McMullan, Premini Mahendra

Transplantation· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution.
Suparno Chakrabarti, Stephen Mackinnon, Raj Chopra, Panagiotis D Kottaridis, Karl Peggs, Premini Mahendra

Blood· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen.
Ronjon Chakraverty, Karl Peggs, Rajesh Chopra, Donald W Milligan, Panagiotis D Kottaridis, Premini Mahendra

Blood· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis